SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Yifeng Lei, Jun Li, Nuoxin Wang, Xinglong Yang, Yoh Hamada, Qizhai Li, Wenfu Zheng, Xingyu Jiang, An on-chip model for investigating the interaction between neurons and cancer cells, Integr. Biol., 2016, 8, 3, 359

    CrossRef

  2. 2
    Lars Ivo Partecke, Sven Speerforck, André Käding, Florian Seubert, Sandra Kühn, Eric Lorenz, Sebastian Schwandke, Matthias Sendler, Wolfram Keßler, Dung Nguyen Trung, Stefan Oswald, Frank Ulrich Weiss, Julia Mayerle, Christin Henkel, Pia Menges, Katharina Beyer, Markus M. Lerch, Claus-Dieter Heidecke, Wolfram von Bernstorff, Chronic stress increases experimental pancreatic cancer growth, reduces survival and can be antagonised by beta-adrenergic receptor blockade, Pancreatology, 2016,

    CrossRef

  3. 3
    Denise Tostes Oliveira, Diego Mauricio Bravo-Calderón, Gustavo Amaral Lauand, Agnes Assao, José-Manuel Suárez-Peñaranda, Mario Pérez-Sayáns, Abel García-García, Aparecido Nilceu Marana, Suely Nonogaki, José Roberto Pereira Lauris, Luiz Paulo Kowalski, Correlation of Beta-2 Adrenergic Receptor Expression in Tumor-Free Surgical Margin and at the Invasive Front of Oral Squamous Cell Carcinoma, Journal of Oncology, 2016, 2016, 1

    CrossRef

  4. 4
    Frank Entschladen, Dane Thyssen, David Drell, Re-Use of Established Drugs for Anti-Metastatic Indications, Cells, 2016, 5, 1, 2

    CrossRef

  5. 5
    Seung Hwa Kim, Kyung Hwa Cho, Yu Na Kim, Bo Young Jeong, Chang Gyo Park, Gang Min Hur, Hoi Young Lee, Resveratrol attenuates norepinephrine-induced ovarian cancer invasiveness through downregulating hTERT expression, Archives of Pharmacal Research, 2016, 39, 2, 240

    CrossRef

  6. 6
    Masae Iwasaki, Matthew Edmondson, Atsuhiro Sakamoto, Daqing Ma, Anesthesia, surgical stress, and “long-term” outcomes, Acta Anaesthesiologica Taiwanica, 2015, 53, 3, 99

    CrossRef

  7. 7
    Florent Elefteriou, Chronic stress, sympathetic activation and skeletal metastasis of breast cancer cells, BoneKEy Reports, 2015, 4, 693

    CrossRef

  8. 8
    Jason W.-L. Eng, Chelsey B. Reed, Kathleen M. Kokolus, Rosemarie Pitoniak, Adam Utley, Mark J. Bucsek, Wen Wee Ma, Elizabeth A. Repasky, Bonnie L. Hylander, Housing temperature-induced stress drives therapeutic resistance in murine tumour models through β2-adrenergic receptor activation, Nature Communications, 2015, 6, 6426

    CrossRef

  9. 9
    M J Choi, K H Cho, S Lee, Y J Bae, K J Jeong, S Y Rha, E J Choi, J H Park, J M Kim, J-S Lee, G B Mills, H Y Lee, hTERT mediates norepinephrine-induced Slug expression and ovarian cancer aggressiveness, Oncogene, 2015, 34, 26, 3402

    CrossRef

  10. 10
    Peder Rustøen Braadland, Håkon Ramberg, Helene Hartvedt Grytli, Kristin Austlid Taskén, β-Adrenergic Receptor Signaling in Prostate Cancer, Frontiers in Oncology, 2015, 4,

    CrossRef

  11. 11
    Luca Filippi, Massimo Dal Monte, Giovanni Casini, Marta Daniotti, Federica Sereni, Paola Bagnoli, Infantile Hemangiomas, Retinopathy of Prematurity and Cancer: A Common Pathogenetic Role of the β-Adrenergic System, Medicinal Research Reviews, 2015, 35, 3
  12. 12
    L Roca-Alonso, L Castellano, A Mills, A F Dabrowska, M B Sikkel, L Pellegrino, J Jacob, A E Frampton, J Krell, R C Coombes, S E Harding, A R Lyon, J Stebbing, Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosis, Cell Death and Disease, 2015, 6, 5, e1754

    CrossRef

  13. 13
    Akira Shimizu, Kyoichi Kaira, Keita Mori, Madoka Kato, Kimihiro Shimizu, Masahito Yasuda, Ayumi Takahashi, Tetsunari Oyama, Takayuki Asao, Osamu Ishikawa, Prognostic significance of β2-adrenergic receptor expression in malignant melanoma, Tumor Biology, 2015,

    CrossRef

  14. 14
    Ping-Ying Chang, Wen-Yen Huang, Cheng-Li Lin, Tzu-Chuan Huang, Yi-Ying Wu, Jia-Hong Chen, Chia-Hung Kao, Propranolol Reduces Cancer Risk, Medicine, 2015, 94, 27, e1097

    CrossRef

  15. 15
    Jheelam Banerjee, Arokya M.S. Papu John, Hildegard M. Schuller, Regulation of nonsmall-cell lung cancer stem cell like cells by neurotransmitters and opioid peptides, International Journal of Cancer, 2015, 137, 12
  16. 16
    Steven W. Cole, Archana S. Nagaraja, Susan K. Lutgendorf, Paige A. Green, Anil K. Sood, Sympathetic nervous system regulation of the tumour microenvironment, Nature Reviews Cancer, 2015, 15, 9, 563

    CrossRef

  17. 17
    Jie Liu, Guo-Hua Deng, Jie Zhang, Ying Wang, Xiang-Yu Xia, Xin-Mei Luo, Yao-Tiao Deng, Sha-Sha He, Yin-Yan Mao, Xing-Chen Peng, Yu-Quan Wei, Yu Jiang, The effect of chronic stress on anti-angiogenesis of sunitinib in colorectal cancer models, Psychoneuroendocrinology, 2015, 52, 130

    CrossRef

  18. 18
    Antonio Barbieri, Sabrina Bimonte, Giuseppe Palma, Antonio Luciano, Domenica Rea, Aldo Giudice, Giosu� Scognamiglio, Elvira La Mantia, Renato Franco, Sisto Perdon�, Ottavio De Cobelli, Matteo Ferro, Silvia Zappavigna, Paola Stiuso, Michele Caraglia, Claudio Arra, The stress hormone norepinephrine increases migration of prostate cancer cells in vitro and in vivo, International Journal of Oncology, 2015,

    CrossRef

  19. 19
    Jessica M Wilson, Ellen Lorimer, Michael D Tyburski, Carol L Williams, β-Adrenergic receptors suppress Rap1B prenylation and promote the metastatic phenotype in breast cancer cells, Cancer Biology & Therapy, 2015, 16, 9, 1364

    CrossRef

  20. 20
    W. Kurtis Childers, Christopher S. Hollenbeak, Pramil Cheriyath, β-Blockers Reduce Breast Cancer Recurrence and Breast Cancer Death: A Meta-Analysis, Clinical Breast Cancer, 2015, 15, 6, 426

    CrossRef

  21. 21
    Florent Elefteriou, Preston Campbell, Bone Cancer, 2015,

    CrossRef

  22. 22
    Evelyn M. Flahavan, Linda Sharp, Kathleen Bennett, Thomas I. Barron, A cohort study of digoxin exposure and mortality in men with prostate cancer, BJU International, 2014, 113, 2
  23. 23
    Sazzad Hassan, Yelena Karpova, Anabel Flores, Ralph D’Agostino, Suzanne C. Danhauer, Ashok Hemal, George Kulik, A pilot study of blood epinephrine levels and CREB phosphorylation in men undergoing prostate biopsies, International Urology and Nephrology, 2014, 46, 3, 505

    CrossRef

  24. 24
    Mark F. McCarty, A role for cAMP-driven transactivation of EGFR in cancer aggressiveness – Therapeutic implications, Medical Hypotheses, 2014, 83, 2, 142

    CrossRef

  25. 25
    Vincenzo Fodale, Maria G. D’Arrigo, Stefania Triolo, Stefania Mondello, Domenico La Torre, Anesthetic Techniques and Cancer Recurrence after Surgery, The Scientific World Journal, 2014, 2014, 1

    CrossRef

  26. 26
    Shahid Akbar, Mansour Saleh Alsharidah, Are Beta Blockers New Potential Anticancer Agents?, Asian Pacific Journal of Cancer Prevention, 2014, 15, 22, 9567

    CrossRef

  27. 27
    Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén, Association Between Use of β-Blockers and Prostate Cancer–Specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-Risk or Metastatic Disease, European Urology, 2014, 65, 3, 635

    CrossRef

  28. 28
    Özlem Darcansoy İşeri, Feride Iffet Sahin, Yunus Kasım Terzi, Erkan Yurtcu, S. Remzi Erdem, Faik Sarialioglu, beta-Adrenoreceptor antagonists reduce cancer cell proliferation, invasion, and migration, Pharmaceutical Biology, 2014, 52, 11, 1374

    CrossRef

  29. 29
    Chris R. Cardwell, Helen G. Coleman, Liam J. Murray, Joe M. O'Sullivan, Des G. Powe, Beta-blocker usage and prostate cancer survival: A nested case–control study in the UK Clinical Practice Research Datalink cohort, Cancer Epidemiology, 2014, 38, 3, 279

    CrossRef

  30. 30
    C. McCourt, H.G. Coleman, L.J. Murray, M.M. Cantwell, O. Dolan, D.G. Powe, C.R. Cardwell, Beta-blocker usage after malignant melanoma diagnosis and survival: a population-based nested case–control study, British Journal of Dermatology, 2014, 170, 4
  31. 31
    Guo-Hua Deng, Jie Liu, Jie Zhang, Ying Wang, Xing-Chen Peng, Yu-Quan Wei, Yu Jiang, Exogenous norepinephrine attenuates the efficacy of sunitinib in a mouse cancer model, Journal of Experimental & Clinical Cancer Research, 2014, 33, 1, 21

    CrossRef

  32. 32
    Hildegard Schuller, Impact of Neuro-Psychological Factors on Smoking-Associated Lung Cancer, Cancers, 2014, 6, 1, 580

    CrossRef

  33. 33
    Jonathan Assayag, Michael N. Pollak, Laurent Azoulay, Post-diagnostic use of beta-blockers and the risk of death in patients with prostate cancer, European Journal of Cancer, 2014, 50, 16, 2838

    CrossRef

  34. 34
    Michael A. Liss, Adam Gordon, Blanca Morales, Kathryn Osann, Douglas Skarecky, Achim Lusch, Frank Zaldivar, Thomas E. Ahlering, Urinary nerve growth factor as an oncologic biomarker for prostate cancer aggressiveness, Urologic Oncology: Seminars and Original Investigations, 2014, 32, 5, 714

    CrossRef

  35. 35
    Carl W White, Jin Han Xie, Sabatino Ventura, Age-related changes in the innervation of the prostate gland, Organogenesis, 2013, 9, 3, 206

    CrossRef

  36. 36
    Ting Xu, Xianmin Xiao, Shan Zheng, Jicui Zheng, Haitao Zhu, Yi Ji, Shaobo Yang, Antiangiogenic effect of propranolol on the growth of the neuroblastoma xenografts in nude mice, Journal of Pediatric Surgery, 2013, 48, 12, 2460

    CrossRef

  37. 37
    Signy Holmes, E. Jane Griffith, Grace Musto, Gerald Y. Minuk, Antihypertensive medications and survival in patients with cancer: A population-based retrospective cohort study, Cancer Epidemiology, 2013, 37, 6, 881

    CrossRef

  38. 38
    John Bauman, Kevin McVary, Autonomic nerve development contributes to prostate cancer progression, Asian Journal of Andrology, 2013, 15, 6, 713

    CrossRef

  39. 39
    C. Magnon, S. J. Hall, J. Lin, X. Xue, L. Gerber, S. J. Freedland, P. S. Frenette, Autonomic Nerve Development Contributes to Prostate Cancer Progression, Science, 2013, 341, 6142, 1236361

    CrossRef

  40. 40
    Sazzad Hassan, Yelena Karpova, Daniele Baiz, Dana Yancey, Ashok Pullikuth, Anabel Flores, Thomas Register, J. Mark Cline, Ralph D’Agostino, Nika Danial, Sandeep Robert Datta, George Kulik, Behavioral stress accelerates prostate cancer development in mice, Journal of Clinical Investigation, 2013,

    CrossRef

  41. 41
    C. R. Cardwell, H. G. Coleman, L. J. Murray, F. Entschladen, D. G. Powe, Beta-blocker usage and breast cancer survival: a nested case-control study within a UK Clinical Practice Research Datalink cohort, International Journal of Epidemiology, 2013, 42, 6, 1852

    CrossRef

  42. 42
    Ming Shi, Dan Liu, Zhengyan Yang, Ning Guo, Central and peripheral nervous systems: master controllers in cancer metastasis, Cancer and Metastasis Reviews, 2013, 32, 3-4, 603

    CrossRef

  43. 43
    Melanie S. Flint, Andrew Baum, Britteny Episcopo, Kelly Z. Knickelbein, Angela J. Liegey Dougall, William H. Chambers, Frank J. Jenkins, Chronic exposure to stress hormones promotes transformation and tumorigenicity of 3T3 mouse fibroblasts, Stress, 2013, 16, 1, 114

    CrossRef

  44. 44
    Kannan Rangiah, Dasaradhi Palakodeti, Comprehensive analysis of neurotransmitters from regenerating planarian extract using an ultrahigh-performance liquid chromatography/mass spectrometry/selected reaction monitoring method, Rapid Communications in Mass Spectrometry, 2013, 27, 21
  45. 45
    Adnan Aydiner, Rumeysa Ciftci, Senem Karabulut, Leyla Kilic, Does Beta-blocker Therapy Improve the Survival of Patients with Metastatic Non-small Cell Lung Cancer?, Asian Pacific Journal of Cancer Prevention, 2013, 14, 10, 6109

    CrossRef

  46. 46
    Manish Kohli, Does Our “Flight and Fight” Response Have a Link With Cancer?, Mayo Clinic Proceedings, 2013, 88, 11, 1185

    CrossRef

  47. 47
    Matteo Monami, Luca Filippi, Andrea Ungar, Federica Sgrilli, Alessandro Antenore, Ilaria Dicembrini, Paola Bagnoli, Niccolò Marchionni, Carlo Maria Rotella, Edoardo Mannucci, Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials, Current Medical Research and Opinion, 2013, 29, 4, 369

    CrossRef

  48. 48
    Florian Heitz, Andreas du Bois, Philipp Harter, Dirk Lubbe, Christian Kurzeder, Ignace Vergote, Marie Plante, Jacobus Pfisterer, Impact of beta blocker medication in patients with platinum sensitive recurrent ovarian cancer—a combined analysis of 2 prospective multicenter trials by the AGO Study Group, NCIC-CTG and EORTC-GCG, Gynecologic Oncology, 2013, 129, 3, 463

    CrossRef

  49. 49
    H. M. Wang, Z. X. Liao, R. Komaki, J. W. Welsh, M. S. O'Reilly, J. Y. Chang, Y. Zhuang, L. B. Levy, C. Lu, D. R. Gomez, Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy, Annals of Oncology, 2013, 24, 5, 1312

    CrossRef

  50. 50
    Caroline P. Le, Tara Karnezis, Marc G. Achen, Steven A. Stacker, Erica K. Sloan, Lymphovascular and neural regulation of metastasis: Shared tumour signalling pathways and novel therapeutic approaches, Best Practice & Research Clinical Anaesthesiology, 2013, 27, 4, 409

    CrossRef

  51. 51
    Steven W. Cole, Nervous system regulation of the cancer genome, Brain, Behavior, and Immunity, 2013, 30, S10

    CrossRef

  52. 52
    Giuseppe Tonini, Loretta D’Onofrio, Emanuela Dell’Aquila, Aldo Pezzuto, New molecular insights in tobacco-induced lung cancer, Future Oncology, 2013, 9, 5, 649

    CrossRef

  53. 53
    Anna-Maria Stock, Desmond G. Powe, Stephan A. Hahn, Gabriele Troost, Bernd Niggemann, Kurt S. Zänker, Frank Entschladen, Norepinephrine inhibits the migratory activity of pancreatic cancer cells, Experimental Cell Research, 2013, 319, 12, 1744

    CrossRef

  54. 54
    Jennifer M. Knight, Jeffrey M. Lyness, Olle Jane Z. Sahler, Jane L. Liesveld, Jan A. Moynihan, Psychosocial factors and hematopoietic stem cell transplantation: Potential biobehavioral pathways, Psychoneuroendocrinology, 2013, 38, 11, 2383

    CrossRef

  55. 55
    N.D. Powell, A.J. Tarr, J.F. Sheridan, Psychosocial stress and inflammation in cancer, Brain, Behavior, and Immunity, 2013, 30, S41

    CrossRef

  56. 56
    George Kulik, Targeting psychoemotional stress to treat prostate cancer, Asian Journal of Andrology, 2013, 15, 3, 362

    CrossRef

  57. 57
    Bjørn S. Madsen, Troels Havelund, Aleksander Krag, Targeting the Gut–Liver Axis in Cirrhosis: Antibiotics and Non-Selective β-Blockers, Advances in Therapy, 2013, 30, 7, 659

    CrossRef

  58. 58
    Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén, Lise Lund Håheim, Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy, The Prostate, 2013, 73, 3
  59. 59
    Jing Tang, Zhijie Li, Lan Lu, Chi Hin Cho, β-Adrenergic system, a backstage manipulator regulating tumour progression and drug target in cancer therapy, Seminars in Cancer Biology, 2013, 23, 6, 533

    CrossRef

  60. 60
    Silvia Moretti, Daniela Massi, Valentina Farini, Gianna Baroni, Matteo Parri, Stefania Innocenti, Roberto Cecchi, Paola Chiarugi, β-adrenoceptors are upregulated in human melanoma and their activation releases pro-tumorigenic cytokines and metalloproteases in melanoma cell lines, Laboratory Investigation, 2013, 93, 3, 279

    CrossRef

  61. 61
    M Pérez-Sayáns, JM Somoza-Martín, F Barros-Angueira, P Gayoso-Diz, EM Otero-Rey, JM Gándra-Rey, A García-García, Activity of β2-adrenergic receptor in oral squamous cell carcinoma is mediated by overexpression of the ADRBK2 gene: a pilot study, Biotechnic & Histochemistry, 2012, 87, 3, 179

    CrossRef

  62. 62
    Elena S. Diaz, Beth Y. Karlan, Andrew J. Li, Impact of beta blockers on epithelial ovarian cancer survival, Gynecologic Oncology, 2012, 127, 2, 375

    CrossRef

  63. 63
    Hussein A.N. Al-Wadei, Mohammad F. Ullah, Mohammed H. Al-Wadei, Intercepting neoplastic progression in lung malignancies via the beta adrenergic (β-AR) pathway: Implications for anti-cancer drug targets, Pharmacological Research, 2012, 66, 1, 33

    CrossRef

  64. You have free access to this content64
    C Pérez Piñero, A Bruzzone, MG Sarappa, LF Castillo, IA Lüthy, Involvement of α2- and β2-adrenoceptors on breast cancer cell proliferation and tumour growth regulation, British Journal of Pharmacology, 2012, 166, 2
  65. 65
    H. Beloeil, K. Nouette-Gaulain, La période périopératoire de chirurgie carcinologique : un moment crucial ! L’anesthésie locorégionale prévient-elle la récidive des cancers ?, Annales Françaises d'Anesthésie et de Réanimation, 2012, 31, 6, 528

    CrossRef

  66. 66
    H. M. Schuller, H. A. N. Al-Wadei, M. F. Ullah, H. K. Plummer, Regulation of pancreatic cancer by neuropsychological stress responses: a novel target for intervention, Carcinogenesis, 2012, 33, 1, 191

    CrossRef

  67. 67
    Jian Huang, Jie Yan, Jian Zhang, Shiguo Zhu, Yanli Wang, Ting Shi, Changhong Zhu, Cheng Chen, Xin Liu, Jinke Cheng, Tomas Mustelin, Gen-Sheng Feng, Guoqiang Chen, Jianxiu Yu, SUMO1 modification of PTEN regulates tumorigenesis by controlling its association with the plasma membrane, Nature Communications, 2012, 3, 911

    CrossRef

  68. 68
    Dongtai Chen, Wei Xing, Jian Hong, Meibing Wang, Yang Huang, Cuizhen Zhu, Yunfei Yuan, Weian Zeng, The Beta2-Adrenergic Receptor is a Potential Prognostic Biomarker for Human Hepatocellular Carcinoma After Curative Resection, Annals of Surgical Oncology, 2012, 19, 11, 3556

    CrossRef

  69. 69
    Carly Lodewyks, Jose F. Rodriguez, Jing Yan, Betty Lerner, DongFeng Sun, Julia D. Rempel, Julia Uhanova, Meaghan Labine, Gerald Y. Minuk, Activation of β-adrenergic receptors increases the in vitro migration of malignant hepatocytes, Hepatology Research, 2011, 41, 10
  70. 70
    D. G. Powe, M. J. Voss, H. O. Habashy, K. S. Zänker, A. R. Green, I. O. Ellis, F. Entschladen, Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study, Breast Cancer Research and Treatment, 2011, 130, 2, 457

    CrossRef

  71. 71
    Christos Vaklavas, Yiannis S. Chatzizisis, Apostolia Maria Tsimberidou, Common cardiovascular medications in cancer therapeutics, Pharmacology & Therapeutics, 2011, 130, 2, 177

    CrossRef

  72. You have free access to this content72
    Sunil M. Shah, Iain M. Carey, Christopher G. Owen, Tess Harris, Stephen DeWilde, Derek G. Cook, Does β-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study, British Journal of Clinical Pharmacology, 2011, 72, 1
  73. You have free access to this content73
    Mark R. Goldstein, Luca Mascitelli, EFFECT OF STATIN USE ON BIOCHEMICAL OUTCOME FOLLOWING RADICAL PROSTATECTOMY, BJU International, 2011, 108, 2
  74. 74
    Helen P.S. Wong, Judy W.C. Ho, Marcel W.L. Koo, Le Yu, William K.K. Wu, Emily K.Y. Lam, Emily K.K. Tai, Joshua K.S. Ko, Vivian Y. Shin, Kent Man Chu, Chi Hin Cho, Effects of adrenaline in human colon adenocarcinoma HT-29 cells, Life Sciences, 2011, 88, 25-26, 1108

    CrossRef

  75. 75
    Hussein A. N. Al-Wadei, Mohammad F. Ullah, Mohammed Al-Wadei, GABA (γ-aminobutyric acid), a non-protein amino acid counters the β-adrenergic cascade-activated oncogenic signaling in pancreatic cancer: A review of experimental evidence, Molecular Nutrition & Food Research, 2011, 55, 12
  76. 76
    Carly Lodewyks, Jose Rodriguez, Jing Yan, Betty Lerner, Jeremy Lipschitz, Charles Nfon, Julia Darlene Rempel, Julia Uhanova, Gerald Yosel Minuk, GABA-B receptor activation inhibits the in vitro migration of malignant hepatocytes, Canadian Journal of Physiology and Pharmacology, 2011, 89, 6, 393

    CrossRef

  77. 77
    Zhi Jie Li, Chi Hin Cho, Neurotransmitters, more than meets the eye — Neurotransmitters and their perspectives in cancer development and therapy, European Journal of Pharmacology, 2011, 667, 1-3, 17

    CrossRef

  78. 78
    Soon Young Park, Joo Hee Kang, Kang Jin Jeong, Jangsoon Lee, Jeong Whan Han, Wahn Soo Choi, Yong Kee Kim, Jaeku Kang, Chang Gyo Park, Hoi Young Lee, Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1α protein-dependent mechanism, International Journal of Cancer, 2011, 128, 10
  79. 79
    Melanie Flint, Kenneth McCarty, Frank Jenkins, Thomas Conrads, Mai Sun, Andrew Baum, Psychological stress accelerates the onset of tumour formation and alters the type and location of tumours in a DMBA mouse carcinogenesis model, Stress and Health, 2011, 27, 3
  80. 80
    J. Hefner, H. Csef, Psychoneuroimmunologie und Krebs, Der Onkologe, 2011, 17, 9, 839

    CrossRef

  81. 81
    M. R. Goldstein, L. Mascitelli, Surgery and cancer promotion: are we trading beauty for cancer?, QJM, 2011, 104, 9, 811

    CrossRef

  82. 82
    Desmond G. Powe, Frank Entschladen, Targeted therapies: Using β-blockers to inhibit breast cancer progression, Nature Reviews Clinical Oncology, 2011, 8, 9, 511

    CrossRef

  83. 83
    Christos Vaklavas, Yiannis S Chatzizisis, The changing perspective of cardiology in cancer care, Expert Review of Cardiovascular Therapy, 2011, 9, 1, 1

    CrossRef

  84. 84
    Tao Shan, Qingyong Ma, Dong Zhang, Kun Guo, Han Liu, Fengfei Wang, Erxi Wu, β2-adrenoceptor blocker synergizes with gemcitabine to inhibit the proliferation of pancreatic cancer cells via apoptosis induction, European Journal of Pharmacology, 2011, 665, 1-3, 1

    CrossRef

  85. 85
    Maria Grazia Perrone, Antonio Scilimati, β3-Adrenoceptor ligand development history through patent review, Expert Opinion on Therapeutic Patents, 2011, 21, 4, 505

    CrossRef

  86. 86
    Hussein A.N. Al-Wadei, Mohammed H. Al-Wadei, Thomas Masi, Hildegard M. Schuller, Chronic exposure to estrogen and the tobacco carcinogen NNK cooperatively modulates nicotinic receptors in small airway epithelial cells, Lung Cancer, 2010, 69, 1, 33

    CrossRef

  87. 87
    Hildegard M Schuller, Hussein AN Al-Wadei, Neurotransmitter receptors as central regulators of pancreatic cancer, Future Oncology, 2010, 6, 2, 221

    CrossRef

  88. 88
    Sylvie Lamy, Marie-Paule Lachambre, Simon Lord-Dufour, Richard Béliveau, Propranolol suppresses angiogenesis in vitro: Inhibition of proliferation, migration, and differentiation of endothelial cells, Vascular Pharmacology, 2010, 53, 5-6, 200

    CrossRef

  89. 89
    Eric V. Yang, Role for catecholamines in tumor progression, Cancer Biology & Therapy, 2010, 10, 1, 30

    CrossRef

  90. 90
    Jason Tilan, Joanna Kitlinska, Sympathetic Neurotransmitters and Tumor Angiogenesis—Link between Stress and Cancer Progression, Journal of Oncology, 2010, 2010, 1

    CrossRef

  91. 91
    Antje Gottschalk, Sonal Sharma, Justin Ford, Marcel E. Durieux, Mohamed Tiouririne, The Role of the Perioperative Period in Recurrence After Cancer Surgery, Anesthesia & Analgesia, 2010, 110, 6, 1636

    CrossRef

  92. 92
    Susan K. Lutgendorf, Koen DeGeest, Caroline Y. Sung, Jesusa M. Arevalo, Frank Penedo, Joseph Lucci, Michael Goodheart, David Lubaroff, Donna M. Farley, Anil K. Sood, Steve W. Cole, Depression, social support, and beta-adrenergic transcription control in human ovarian cancer, Brain, Behavior, and Immunity, 2009, 23, 2, 176

    CrossRef

  93. 93
    Zheng Jun Shang, Ke Liu, De Feng Liang, Expression of β2-adrenergic receptor in oral squamous cell carcinoma, Journal of Oral Pathology & Medicine, 2009, 38, 4
  94. 94
    Hildegard M. Schuller, Is cancer triggered by altered signalling of nicotinic acetylcholine receptors?, Nature Reviews Cancer, 2009, 9, 3, 195

    CrossRef

  95. 95
    Paul J. Fitzgerald, Is norepinephrine an etiological factor in some types of cancer?, International Journal of Cancer, 2009, 124, 2
  96. 96
    H. A. N. Al-Wadei, H. K. Plummer, H. M. Schuller, Nicotine stimulates pancreatic cancer xenografts by systemic increase in stress neurotransmitters and suppression of the inhibitory neurotransmitter  -aminobutyric acid, Carcinogenesis, 2009, 30, 3, 506

    CrossRef

  97. 97
    Hussein AN Al-Wadei, Hildegard M Schuller, Nicotinic receptor-associated modulation of stimulatory and inhibitory neurotransmitters in NNK-induced adenocarcinoma of the lungs and pancreas, The Journal of Pathology, 2009, 218, 4
  98. 98
    Eric V. Yang, Seung-jae Kim, Elise L. Donovan, Min Chen, Amy C. Gross, Jeanette I. Webster Marketon, Sanford H. Barsky, Ronald Glaser, Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: Implications for stress-related enhancement of tumor progression, Brain, Behavior, and Immunity, 2009, 23, 2, 267

    CrossRef

  99. 99
    Hussein A. Al-Wadei, Mohammed H. Al-Wadei, Hildegard M. Schuller, Prevention of pancreatic cancer by the beta-blocker propranolol, Anti-Cancer Drugs, 2009, 20, 6, 477

    CrossRef

  100. 100
    Philipp Bastian, Agnieszka Balcarek, Christina Altanis, Carina Strell, Bernd Niggemann, Kurt S. Zaenker, Frank Entschladen, The inhibitory effect of norepinephrine on the migration of ES-2 ovarian carcinoma cells involves a Rap1-dependent pathway, Cancer Letters, 2009, 274, 2, 218

    CrossRef

  101. 101
    Maria Grazia Perrone, Laura Bleve, Ernesto Santandrea, Paola Vitale, Mauro Niso, Antonio Scilimati, The Tertiary Amine Nitrogen Atom of Piperazine Sulfonamides as a Novel Determinant of Potent and Selective β3-Adrenoceptor Agonists, ChemMedChem, 2009, 4, 12
  102. 102
    Carmen Rodriguez, Eric J. Jacobs, Anusila Deka, Alpa V. Patel, Elizabeth B. Bain, Michael J. Thun, Eugenia E. Calle, Use of blood-pressure-lowering medication and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort, Cancer Causes & Control, 2009, 20, 5, 671

    CrossRef

  103. 103
    Eric V Yang, Don M Benson, Ronald Glaser, Catecholamines can mediate stress-related effects on tumor progression, Expert Review of Endocrinology & Metabolism, 2008, 3, 6, 699

    CrossRef

  104. 104
    Hildegard M. Schuller, Hussein A. N. Al-Wadei, Mourad Majidi, GABAB receptor is a novel drug target for pancreatic cancer, Cancer, 2008, 112, 4
  105. 105
    H. M. Schuller, H. A.N. Al-Wadei, M. Majidi, Gamma-aminobutyric acid, a potential tumor suppressor for small airway-derived lung adenocarcinoma, Carcinogenesis, 2008, 29, 10, 1979

    CrossRef

  106. 106
    Håkon Ramberg, Turid Eide, Kurt Allen Krobert, Finn Olav Levy, Nishtman Dizeyi, Anders S Bjartell, Per-Anders Abrahamsson, Kristin Austlid Taskén, Hormonal regulation of β2-adrenergic receptor level in prostate cancer, The Prostate, 2008, 68, 10
  107. 107
    Hongjuan Zhao, Rosalie Nolley, Zuxiong Chen, Stephen W. Reese, Donna M. Peehl, Inhibition of monoamine oxidase A promotes secretory differentiation in basal prostatic epithelial cells, Differentiation, 2008, 76, 7
  108. 108
    Patricia S Steeg, Dan Theodorescu, Metastasis: a therapeutic target for cancer, Nature Clinical Practice Oncology, 2008, 5, 4, 206

    CrossRef

  109. 109
    Premal H. Thaker, Anil K. Sood, Neuroendocrine influences on cancer biology, Seminars in Cancer Biology, 2008, 18, 3, 164

    CrossRef

  110. 110
    Hildegard M. Schuller, Neurotransmission and cancer: implications for prevention and therapy, Anti-Cancer Drugs, 2008, 19, 7, 655

    CrossRef

  111. 111
    Yori Gidron, Alain Ronson, Psychosocial factors, biological mediators, and cancer prognosis: a new look at an old story, Current Opinion in Oncology, 2008, 20, 4, 386

    CrossRef

  112. 112
    Paul Kelly, The cancer critical care paradox, Current Anaesthesia & Critical Care, 2008, 19, 2, 96

    CrossRef

  113. 113
    Frank Entschladen, Daniel Palm, Bernd Niggemann, Kurt S. Zaenker, The cancer's nervous tooth: Considering the neuronal crosstalk within tumors, Seminars in Cancer Biology, 2008, 18, 3, 171

    CrossRef

  114. 114
    Max Jellinek, The need for a multi-level biochemical approach to defeat cancer that will also support the host, Medical Hypotheses, 2008, 71, 4, 515

    CrossRef

  115. 115
    Helen Pui Shan Wong, Le Yu, Emily Kai Yee Lam, Emily Kin Ki Tai, William Ka Kei Wu, Chi Hin Cho, Nicotine promotes cell proliferation via α7-nicotinic acetylcholine receptor and catecholamine-synthesizing enzymes-mediated pathway in human colon adenocarcinoma HT-29 cells, Toxicology and Applied Pharmacology, 2007, 221, 3, 261

    CrossRef